RELATING TO RARE DISEASES.

2025 Regular Session Introduced by Cory Chun and 8 co-sponsors

Bill HB 910 establishes an advisory council to improve treatment access, insurance coverage, and support for patients with rare diseases, enhancing their healthcare outcomes.

Introduced and Pass First Reading.

#advisorycouncil #geneticdisorders #insurance($) #rarediseases

Purpose and Intent

Bill HB 910 aims to address the challenges faced by individuals with rare diseases by establishing an advisory council focused on genetic disorders and insurance coverage. The intent is to improve awareness, access to treatment, and support for patients suffering from rare diseases, which often receive limited attention in healthcare policy.

Key Provisions

Establishment of an Advisory Council: The bill proposes the creation of an advisory council dedicated to rare diseases. This council will consist of healthcare professionals, patient advocates, and representatives from relevant organizations.

Focus Areas: The council will focus on:

Research and Awareness: Promoting research initiatives and raising public awareness about rare diseases.
Insurance Coverage: Evaluating and recommending improvements to insurance policies to ensure adequate coverage for treatments related to rare diseases.
Support Services: Identifying and advocating for support services for patients and families affected by rare diseases.

Funding Considerations: While specific dollar amounts are not detailed in the bill, it indicates a need for financial resources to support the council's activities and initiatives.

Who Would Be Affected

Patients with Rare Diseases: Individuals diagnosed with rare diseases will benefit from improved access to treatments and support services.

Healthcare Providers: Medical professionals will gain insights and resources to better understand and treat rare diseases.

Insurance Companies: The bill may lead to changes in insurance policies, affecting how coverage for rare diseases is structured.

Procedural Aspects

Introduced Date: The bill was introduced on January 21, 2025.

Legislative Actions:

First Reading: The bill passed its first reading on January 23, 2025.
Referral: It has been referred to the Health, Education, and Human Services (HLT/EDN), Consumer Protection and Commerce (CPC), and Finance (FIN) committees for further consideration.

Conclusion

Bill HB 910 represents a significant step towards enhancing the support and resources available for individuals affected by rare diseases. By establishing an advisory council, the bill seeks to foster collaboration among stakeholders and improve healthcare outcomes for this underserved population. As the bill progresses through the legislative process, its provisions may evolve to better address the needs of patients and the healthcare system.

Bill